6 Yan L, Tan X Q, Chen W X, et al. Enhanced vasoconstriction to a1 adrenoceptor autoantibody in spontaneously hypertensive rats. Sci China Life Sci, 2014, 57: 681-689
[4]
12 Demaurex N, El Chemaly A. Physiological roles of voltage-gated proton channels in leukocytes. J Physiol, 2010, 588: 4659-4665
[5]
13 Moreno C, Prieto P, Macías á, et al. Modulation of voltage-dependent and inward rectifier potassium channels by 15-epi-lipoxin-A4 in activated murine macrophages: implications in innate immunity. J Immunol, 2013, 191: 6136-6146
[6]
14 Vicente R, Escalada A, Soler C, et al. Pattern of Kvb subunit expression in macrophages depends upon proliferation and the mode of activation. J Immunol, 2005, 174: 4736-4744
[7]
15 Yang Y, Wang Y F, Yang X F, et al. Specific Kv1.3 blockade modulates key cholesterol-metabolism-associated molecules in human macrophages exposed to ox-LDL. J Lipid Res, 2013, 54: 34-43
[8]
16 Leanza L, Zoratti M, Gulbins E, et al. Induction of apoptosis in macrophages via Kv1.3 and Kv1.5 potassium channels. Curr Med Chem, 2012, 19: 5394-5404
[9]
17 Villalonga N, David M, Bielanska J. Immunomodulatory effects of diclofenac in leukocytes through the targeting of Kv1.3 voltage-dependent potassium channels. Biochem Pharmacol, 2010, 80: 858-866
[10]
18 Ell Wulff H, Castle N A, Pardo L A. Voltage-gated potassium channels as therapeutic targets. Nat Rev Drug Discov, 2009, 8: 982-1001
[11]
19 Pardo L A. Voltage-gated potassium channels in cell proliferation. Physiology, 2004, 19: 285-292
[12]
20 Bradding P, Wulff H. The K+ channels KCa3.1 and Kv1.3 as novel targets for asthma therapy. Brit J Pharmacol, 2009, 157: 1330-1339
[13]
21 Lei X, Ma A, Xi Y, et al. Inhibitory effects of blocking voltage-dependent potassium channel 1.3 on human monocyte-derived macrophage differentiation into foam cells. J Peking Univ (Health Sci), 2006, 38: 257-261
[14]
22 Pennington M W, Harunur Rashid M, Tajhya R B, et al. A C-terminally amidated analogue of ShK is a potent and selective blocker of the voltage-gated potassium channel Kv1.3. FEBS Lett, 2012, 586: 3996-4001
[15]
25 Wang M, Zhao D, Yang Y, et al. The cellular prion protein negatively regulates phagocytosis and cytokine expression in murine bone marrow-derived macrophages. PLoS One, 2014, 9: e102785
[16]
26 Tartaro K, VanVolkenburg M, Wilkie D, et al. Development of a fluorescence-based in vivo phagocytosis assay to measure mononuclear phagocyte system function in the rat. J Immunotoxicol, 2014, 16: 1-8
[17]
27 Zhang M, Behrens E M, Atkinson T P, et al. Genetic defects in cytolysis in macrophage activation syndrome. Curr Rheumatol Rep, 2014, 16: 439
[18]
28 Hsieh C H, Nickel E A, Chen J, et al. Mechanism of the salutary effects of estrogen on Kupffer cell phagocytic capacity following trauma-hemorrhage: pivotal role of Akt activation. J Immunol, 2009, 182: 4406-4414
[19]
1 Cahalan M D, Chandy K G. The functional network of ion channels in T lymphocytes. Immunol Rev, 2009, 231: 59-87
[20]
2 Qiu M, Campbell T, Breit S. A potassium ion channel is involved in cytokine production. Clin Exp Immuonl, 2002, 130: 67-74
[21]
3 Villalonga N, David M, Bielanska J, et al. Immunomodulation of voltage-dependent K+ channels in macrophages: molecular and biophysical consequences. J Gen Physiol, 2010, 135: 135-147
[22]
7 Vicente R, Escalada A, Coma M, et al. Differential voltage-dependent K+ channel responses during proliferation and activation in macrophages. J Biol Chem, 2003, 278: 46307-46320
[23]
8 Vicente R, Escalada A, Villalonga N, et al. Association of Kv1.5 and Kv1.3 contributes to the major voltage-dependent K+ channel in macrophages. J Biol Chem, 2006, 281: 37675-37685
[24]
9 Lam J, Wulff H. The lymphocyte potassium channels Kv1.3 and KCa3.1 as targets for immunosuppression. Drug Dev Res, 2011, 72: 573-584
[25]
10 Gao Y D, Hanley P J, Rinné S, et al. Calcium-activated K+ channel (K(Ca)3.1) activity during Ca2+ store depletion and store-operated Ca2+ entry in human macrophages. Cell Calcium, 2010, 48: 19-27
[26]
11 Tano J Y, Lee R H, Vazquez G. Macrophage function in atherosclerosis: potential roles of TRP channels. Channels (Austin), 2012, 6: 141-148
[27]
23 Matheu M P, Beeton C. Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block. Immunity, 2008, 29: 602-614
[28]
24 Datta K, Soni J L, Awadhiya R P, et al. Erythrophagocytosis in phenylhydrazine induced acute anaemia in chickens. Res Vet Sci, 1989, 47: 136-137
[29]
29 Zhou X, Yang W, Li J. Ca2+- and protein kinase C-dependent signaling pathway for nuclear factor-kB activation, inducible nitric-oxide synthase expression, and tumor necrosis factor-a production in lipopolysaccharide-stimulated rat peritoneal macrophages. J Biol Chem, 2006, 281: 31337-31347
[30]
30 Turner M D, Nedjai B, Hurst T, et al. Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta, 2014, 1843: 2563-2582
[31]
31 Schulert G S, Grom A A. Macrophage activation syndrome and cytokine-directed therapies. Best Pract Res Clin Rheumatol, 2014, 28: 277-292
[32]
32 Striz I, Brabcova E, Kolesar L, et al. Cytokine networking of innate immunity cells: a potential target of therapy. Clin Sci (Lond), 2014, 126: 593-612
34 Kong L, Ge B X. MyD88-independent activation of a novel actin-Cdc42/Rac pathway is required for Toll-like receptor-stimulated phagocytosis. Cell Res, 2008, 18: 745-755
[35]
35 Martínez-Mármol R, Villalonga N, Solé L, et al. Multiple Kv1.5 targeting to membrane surface microdomains. J Cell Physiol, 2008, 217: 667-673
[36]
36 Vicente R. Differential voltage-dependent K+ channel responses during proliferation and activation in macrophages J Biol Chem, 2003, 278: 46307-46320
